These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23946417)

  • 1. Neurological picture. Neurological ornithology.
    McKinley JJ; McCarthy A; Kavanagh E; Lynch T
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):239-40. PubMed ID: 23946417
    [No Abstract]   [Full Text] [Related]  

  • 2. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Antonini A; Benti R; De Notaris R; Tesei S; Zecchinelli A; Sacilotto G; Meucci N; Canesi M; Mariani C; Pezzoli G; Gerundini P
    Neurol Sci; 2003 Oct; 24(3):149-50. PubMed ID: 14598060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
    Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
    J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive Supranuclear Palsy-like Syndrome from Possible Cerebral Amyloid Angiopathy.
    Shetty A; Camicioli R; Ba F
    Can J Neurol Sci; 2019 Jan; 46(1):132-136. PubMed ID: 30457071
    [No Abstract]   [Full Text] [Related]  

  • 5. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
    Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
    Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of MRI in the diagnosis of progressive supranuclear palsy].
    Vérin M; Defebvre L; Delmaire C; Rolland Y
    Rev Neurol (Paris); 2005 Feb; 161(2):234-6. PubMed ID: 15798526
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy.
    Gröschel K; Kastrup A; Litvan I; Schulz JB
    Neurology; 2006 Mar; 66(6):949-50. PubMed ID: 16567726
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive supranuclear palsy and Parkinson's disease overlap: A clinicopathological case report.
    Araki K; Sumikura H; Matsudaira T; Sugiura A; Takao M; Murayama S; Obi T
    Neuropathology; 2016 Apr; 36(2):187-91. PubMed ID: 26388542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Echolalia and progressive supranuclear palsy, an unexpected association].
    Fernández-Pajarín G; Sesar Á; Ares-Pensado B; Jiménez-Martín I; Castro A
    Rev Neurol; 2015 Aug; 61(3):143-4. PubMed ID: 26178519
    [No Abstract]   [Full Text] [Related]  

  • 14. Teaching NeuroImages: "Penguin" or "hummingbird" sign and midbrain atrophy in progressive supranuclear palsy.
    Graber JJ; Staudinger R
    Neurology; 2009 Apr; 72(17):e81. PubMed ID: 19398699
    [No Abstract]   [Full Text] [Related]  

  • 15. Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study.
    Arnold G; Tatsch K; Kraft E; Oertel WH; Schwarz J
    Mov Disord; 2002 May; 17(3):557-62. PubMed ID: 12112207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lesion of the dorsorostral midbrain sparing the nigrostriatal tract mimics axial rigidity seen in progressive supranuclear palsy.
    Lewerenz J; Zurowski B; Jenicke L; Bäumer T; Lees AJ; Münchau A
    Mov Disord; 2005 Aug; 20(8):1071-5. PubMed ID: 15838851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.
    Morelli M; Arabia G; Messina D; Vescio B; Salsone M; Chiriaco C; Perrotta P; Rocca F; Cascini GL; Barbagallo G; Nigro S; Quattrone A
    Mov Disord; 2014 Apr; 29(4):488-95. PubMed ID: 24573655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses.
    Park HK; Kim JS; Im KC; Oh SJ; Kim MJ; Lee JH; Chung SJ; Lee MC
    Mov Disord; 2009 Jan; 24(2):237-45. PubMed ID: 18951539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can mid-sagittal MRI be used to diagnose progressive supranuclear palsy?
    Reich SG
    Nat Clin Pract Neurol; 2006 Jan; 2(1):12-3. PubMed ID: 16932511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interobserver bias in detecting the penguin-silhouette sign].
    Romero JO
    Neurologia; 2007 Oct; 22(8):557-8. PubMed ID: 18000766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.